RGEDF (Chemical Works of Gedeon Richter) Retained Earnings: $4,359 Mil (As of Dec. 2025)


RGEDF Chemical Works of Gedeon Richter PLC RGEDF
94 GF Score
Price $39.18
GF Value $35.26
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter Retained Earnings?

Chemical Works of Gedeon Richter RGEDF +3.18% 94 Retained Earnings is $4,359 Mil as of Dec. 2025. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.26 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Chemical Works of Gedeon Richter's retained earnings for the quarter that ended in Dec. 2025 was $4,359 Mil.

Chemical Works of Gedeon Richter's quarterly retained earnings declined from Mar. 2025 ($4,132 Mil) to Jun. 2025 ($4,000 Mil) but then increased from Jun. 2025 ($4,000 Mil) to Dec. 2025 ($4,359 Mil).

Chemical Works of Gedeon Richter's annual retained earnings increased from Dec. 2023 ($3,417 Mil) to Dec. 2024 ($3,909 Mil) and increased from Dec. 2024 ($3,909 Mil) to Dec. 2025 ($4,359 Mil).


Chemical Works of Gedeon Richter  (OTCPK:RGEDF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Chemical Works of Gedeon Richter Retained Earnings Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter Retained Earnings Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,725.34 3,142.72 3,417.01 3,909.46 4,358.90

Chemical Works of Gedeon Richter Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,588.78 3,909.46 4,131.66 4,000.21 4,358.90
RGEDF
94GF Score
Chemical Works of Gedeon Richter PLC RGEDF
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $4,359 Mil mean?
Chemical Works of Gedeon Richter (RGEDF) has a Retained Earnings of $4,359 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Chemical Works of Gedeon Richter and its competitors.
Is Chemical Works of Gedeon Richter's Retained Earnings too high?
Chemical Works of Gedeon Richter's current Retained Earnings is $4,359 Mil. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's Retained Earnings compare to ZTS and UTHR?
Chemical Works of Gedeon Richter's Retained Earnings of $4,359 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Drug Manufacturers company?
A good Retained Earnings depends on the Drug Manufacturers industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Chemical Works of Gedeon Richter and its competitors. Chemical Works of Gedeon Richter's current Retained Earnings is $4,359 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.26, compared to a current price of $39.18 — trading 11.1% above its estimated fair value. The current Retained Earnings is $4,359 Mil. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current Retained Earnings is $4,359 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of $39.18 is trading 11.1% above its estimated GF Value™ of $35.26. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for RGEDF:

  • Retained Earnings: $4,359 Mil
  • GF Value™: $35.26 vs. price of $39.18 (11.1% above fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score

Get the complete analysis for RGEDF

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.18
Price
$35.26
GF Value